PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26708109-0	2016	Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARgamma activators.	barbituric acid	39-54	peroxisome proliferator activated receptor gamma	Homo sapiens	70-79	
26708109-7	2016	The most significant finding of our study is that BA derivatives with symmetrically substituted weakly polar side chains result in the desired moderate level of PPARgamma binding affinities.	barbituric acid	50-52	peroxisome proliferator activated receptor gamma	Homo sapiens	161-170	
21463618-0	2011	A novel agonist of PPAR-gamma based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.	barbituric acid	39-54	peroxisome proliferator activated receptor gamma	Homo sapiens	19-29	
21463618-2	2011	Recently, a new series of PPARgamma ligands based on barbituric acid has been designed, in which 5-(4-(benzyloxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (SKLB102) showed a high affinity with PPARgamma.	barbituric acid	53-68	peroxisome proliferator activated receptor gamma	Homo sapiens	26-35	
21463618-2	2011	Recently, a new series of PPARgamma ligands based on barbituric acid has been designed, in which 5-(4-(benzyloxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (SKLB102) showed a high affinity with PPARgamma.	barbituric acid	53-68	peroxisome proliferator activated receptor gamma	Homo sapiens	197-206